FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only

NCT01226719 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Panitumumab
DRUG: Oxaliplatin
DRUG: Irinotecan
DRUG: Leucovorin
DRUG: 5-Fluorouracil

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]